| Size: 110 KB 3rd May 2022 Cross-Sectional Study on Factors Associated with Symptoms of Anxiety among People with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study | Size: 106 KB 3rd May 2022 Cross-Sectional Study on Factors Associated with Symptoms of Depression among People with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study | Size: 123 KB 3rd May 2022 Effectiveness and safety of tofacitinib in Canadian patients with rheumatoid arthritis with vs without cardiovascular risk factors: a subgroup analysis of the multicentre, observational CANTORAL study | Size: 149 KB 3rd May 2022 Use and Perceptions of Nutrition Information Resources Among People with Systemic Sclerosis from the Scleroderma Patient-centered Intervention Network (SPIN) Cohort | Size: 107 KB 3rd May 2022 Effectiveness and safety of tofacitinib in Canadian patients with rheumatoid arthritis: primary results from a multicentre, observational study | Size: 118 KB 3rd May 2022 Seronegative Polyarthritis in Association with Anti-NXP2 Autoantibodies: A Case Series and Literature Review | Size: 102 KB 3rd May 2022 A Cross-Sectional Study of Factors Associated with Sleep Disturbance in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study
| Size: 135 KB 28th May 2019 The Differential Expression of CLEC12A on Neutrophils of Rheumatoid arthritis Patients Correlates with Clinical Parameters. | Size: 137 KB 28th May 2019 JAK Inhibitors: a Promising Molecular-Targeted Therapy in Dermatomyositis. | Size: 138 KB 28th May 2019 Severe Axial and Pelvi-femoral Muscle Damage in Immune-Mediated Necrotizing Myopathy evaluated by Whole-body MRI. | Size: 133 KB 28th May 2019 Association Between Immunosuppressive Therapy and Course of Mild Interstitial Lung Disease in Systemic Scleroderma. | Size: 135 KB 28th May 2019 No Time to Lose: A Case of Severe Multifocal Aneurysmal Vasculitis. | Size: 134 KB 28th May 2019 Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus. | Size: 135 KB 28th May 2019 Effects of Strength Training on Participation and Health Related Quality of Life in Rheumatoid Arthritis. | Size: 135 KB 28th May 2019 Comparison of first biologic drug persistence in patients with ankylosis spondylitis and non-radiographic axial spondyloarthritis: data from the SPARCC registry. | Size: 136 KB 28th May 2019 Identifying Barriers and Facilitators to Physical Activity for People with Scleroderma: A Nominal Group Technique Study. | Size: 136 KB 28th May 2019 Probability of Achieving Low Disease Activity or Remission in Subjects With Active Psoriatic Arthritis Treated With Apremilast. | Size: 137 KB 28th May 2019 Achievement of cDAPSA Low Disease Activity or Remission Is Associated With Control of Articular and Extra-Articular Manifestations of Active Psoriatic Arthritis in Subjects Treated With Apremilast. | Size: 138 KB 28th May 2019 Low Interstitial Lung Disease Event Rate in Patients with Rheumatoid Arthritis: Pooled Post Hoc Analysis of Data from the Tofacitinib Clinical Development Program. | Size: 134 KB 28th May 2019 The Development of a Novel, Targeted and Less Toxic Anti-Inflammatory Drug for the Treatment of Gout. | Size: 135 KB 28th May 2019 Characterization of the Signaling Pathway of CLEC12A: An Inhibitory Receptor involved in Gout. | Size: 137 KB 28th May 2019 Chronic Disease Course and IV Ig-Dependence in Long-term Follow-up of Anti-HMGCR Immune-Mediated Necrotizing Myopathy. | Size: 139 KB 28th May 2019 Physical Activity Monitoring using Wrist-Worn Accelerometer in the Assessment of Patients with Myositis. | Size: 134 KB 28th May 2019 Resistance Training Improves Physical Function, and Body Composition in People with Rheumatoid Arthritis. | Size: 133 KB 28th May 2019 Challenges to Optimal Rheumatology Care: A focus Group study. | Size: 135 KB 28th May 2019 Stressful Life Events are Relation to RA Diagnosis and Presenting Characteristics: Results from the Canadian Early Arthritis Cohort (CATCH). | Size: 137 KB 28th May 2019 Factors Influencing Patient Interest in Participating in an Online Self-care Intervention: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study. | Size: 136 KB 28th May 2019 The Scleroderma Patient-centered Intervention Network (SPIN): Engaging Patients in Rheumatology Research.
| Size: 201 KB 9th May 2018 Patterns of aspirin use in SLE pregnancies within a multinational inception cohort | Size: 196 KB 9th May 2018 Association between Immunosuppression and Risk of New Onset Interstitial Lung Disease in Systemic Sclerosis | Size: 199 KB 9th May 2018 Involvement of TLR-9 pathway on NK cells in Systemic Lupus Erythematosus | Size: 196 KB 9th May 2018 Low resting energy metabolism, higher fat, and greater fatigue in sedentary patients with rheumatoid arthritis | Size: 198 KB 9th May 2018 Building the Arthritis Alliance of Canada Quality Framework: Development of a patient-centered balanced scorecard approach to improve quality of care in rheumatoid arthritis (RA) patients in Canada | Size: 197 KB 9th May 2018 Potential communication failures at hospital discharge may compromise SLE care | Size: 197 KB 9th May 2018 Thick as Thieves: A curious Case of Sjögren's Syndrome | Size: 197 KB 9th May 2018 Myosite anti PM-SCL75 | Size: 198 KB 9th May 2018 A Unique Case of Stevens–Johnson Syndrome and Giant Cell Arteritis | Size: 196 KB 9th May 2018 Vasculite du système nerveux central à BCG | Size: 196 KB 9th May 2018 Structure-Function Analysis of Clec12A, an Inhibitory Receptor Associated with Chronic Inflammatory Diseases | Size: 199 KB 9th May 2018 Long-term (4-Year) Efficacy and Safety of Apremilast Monotherapy in DMARD-Naïve Subjects With Active Psoriatic Arthritis | Size: 200 KB 9th May 2018 Consistent Safety Profile With Up to 4 Years of Apremilast Treatment: Analysis of Data From 1,493 Subjects With Psoriatic Arthritis in 3 Large, Phase III, Long-term Studies | Size: 199 KB 9th May 2018 Characterization of Clinical Benefits in Subjects Classified as ACR20 Non-responders at Week 104 of Apremilast Treatment: Subanalysis of 3 Long-term, Phase III Trials | Size: 200 KB 9th May 2018 Low Rates of Major Adverse Cardiac Events, Malignancies, and Serious Infections in Subjects With Psoriasis and Psoriatic Arthritis Treated With Apremilast for ≥156 Weeks: Pooled Analysis From the ESTEEM and PALACE 1-3 Phase 3 Trials | Size: 200 KB 9th May 2018 Safety and efficacy of tofacitinib, an oral Janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of OPAL Balance, an open-label, long-term extension study | Size: 198 KB 9th May 2018 Marital status and age of systemic lupus erythematous diagnosis | Size: 195 KB 9th May 2018 Fatigue Measurements in Systemic Lupus Erythematosus | Size: 198 KB 9th May 2018 The Prevalence of Electrocardiographic Conduction Abnormalities in Systemic Sclerosis is very Similar to that found in Healthy Individuals: Data from the Canadian Scleroderma Research Group | Size: 198 KB 9th May 2018 Cardiac magnetic resonance imaging role in systemic sclerosis-associated pulmonary hypertension: Analysis of 78 patients. | Size: 197 KB 9th May 2018 aregiving intensity and perceived burden among informal caregivers of persons with systemic sclerosis compared to other chronic medical conditions | Size: 196 KB 9th May 2018 Pulmonary Hypertrophic Osteoarthropathy in a Cystic Fibrosis Patient. | Size: 201 KB 9th May 2018 Body Composition and Bone Health Among Sedentary Young Adults with and without Inflammatory Arthritis
| Size: 50 KB 29th Mar 2018 Joint Pain in Relation to Changes in Weight and Body Composition in People Undergoing Bariatric Surgery | Size: 52 KB 29th Mar 2018 Syndrome de Mullin | Size: 52 KB 29th Mar 2018 Time to Pregnancy in Women with Systemic Lupus Erythematosus | Size: 51 KB 29th Mar 2018 La maladie de Behçet intestinal | Size: 52 KB 29th Mar 2018 The association of sociodemographic and disease variables with hand function: A Scleroderma Patient-centred Intervention Network (SPIN) Cohort study | Size: 51 KB 29th Mar 2018 Experience with tofacitinib in Canada: Rheumatoid arthritis patient characteristics and treatment patterns from 2014 to 2016 | Size: 50 KB 29th Mar 2018 Prevalence of Joint Pain Before and After Bariatric Surgery and Impact on Physical Activity | Size: 47 KB 29th Mar 2018 Implementation and evaluation of inflammatory arthritis models of care in Canada | Size: 49 KB 29th Mar 2018 CLINICAL CHARACTERISTICS OF SPONDYLARTHRITIS WITH AND WITHOUT PERIPHERAL ENTHESITIS – DATA FROM THE DESIR COHORT | Size: 50 KB 29th Mar 2018 Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-World | Size: 48 KB 29th Mar 2018 Real-World Efficacy of Anti-TNF in Psoriatic Arthritis Patients with Enthesitis and Correlation of Enthesitis with Tender / Swollen Joints | Size: 47 KB 29th Mar 2018 Informal Caregivers for Scleroderma Focus Groups | Size: 47 KB 29th Mar 2018 Exploring coping strategies among people living with scleroderma through focus groups: A Scleroderma Patient-centered Intervention Network Study | Size: 45 KB 29th Mar 2018 Subclinical Enthesopathy in Psoriatic Patients and its Relation to Other Disease Parameters: An Ultrasound Study
| Size: 54 KB 4th May 2016 Corrélation d’allèles de polymorphismes nucléotidiques (SNP) dans les gènes de l’interleukine-4 (IL-4) et de son récepteur (IL-4R) et du locus CD40 avec les issues cliniques et radiographiques chez des patients avec polyarthrite inflammatoire d’installation récente traités en visant la remission | Size: 50 KB 4th May 2016 Rheumatic and Non-Rheumatic Autoimmune Diseases in SLE Offspring | Size: 56 KB 4th May 2016 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (104-Week) Improvement in Fatigue in Patients With Psoriatic Arthritis: Pooled Results From 3 Phase III, Randomized, Controlled Trials | Size: 59 KB 4th May 2016 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Improves Nail and Scalp Psoriasis and PASI Scores in Patients With Moderate to Severe Plaque Psoriasis. | Size: 63 KB 4th May 2016 Clinical and histological improvement during 5 years of treatment of a woman with Muckle-Wells Syndrome | Size: 48 KB 4th May 2016 Le cas de madame V: une histoire qui a du piquant. | Size: 305 KB 4th May 2016 Lorsque la polychondrite récidivante atteint les lobes d’oreille… | Size: 44 KB 4th May 2016 Un cas de calcinose extensive. | Size: 47 KB 4th May 2016 Single-specificity anti-Ku antibodies in a tri-nation cohort of 2140 systemic sclerosis subjects: clinical associations | Size: 48 KB 4th May 2016 Outcomes in mothers with rheumatic diseases and their offspring workshop | Size: 47 KB 4th May 2016 Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: a Systematic Review | Size: 51 KB 4th May 2016 Increased Risk of Allergic Conditions in Children Born to Women with SLE | Size: 46 KB 4th May 2016 The Scleroderma Support Group Non-Attenders Survey: A Cross-sectional Study | Size: 43 KB 4th May 2016 Exercise Habits and Associated Factors in Scleroderma: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study | Size: 51 KB 4th May 2016 Risk of Ocular Anomalies in Children Exposed in Utero to Antimalarials: Data from the Offspring of SLE mothers Registry | Size: 43 KB 4th May 2016 Risk of Lung Cancer in Rheumatoid Arthritis Patients | Size: 53 KB 4th May 2016 Clinical Characteristics, Laboratory Findings and Nailfold Capillaroscopy Microscopy Patterns in a Monocentric Series of 123 Patients with Idiopathic Pernio | Size: 44 KB 4th May 2016 Malignancy in juvenile idiopathic arthritis
| Size: 226 KB 6th Oct 2015 Rôle de la résolvine D1 dans la régulation des réponses inflammatoires et cataboliques de l’arthrose | Size: 218 KB 6th Oct 2015 A novel myopathy, two very different phenotypes: the French Canadian Experience. | Size: 228 KB 6th Oct 2015 Atorvastatin-Induced Autoimmune Myopathy: An Emerging Dominant Entity in Patients with Autoimmune Myopathy Presenting with a Pure Polymyositis Phenotype. | Size: 223 KB 6th Oct 2015 The anti-MDA5 autoantibody phenotype: Defining clinical, biochemical and radiological features suggestive of anti-MDA5-associated rapidly progressive interstitial lung disease. | Size: 242 KB 6th Oct 2015 CRP and 14-3-3η are each associated with joint damage progression, their titres do not correlate and are better predictors of progression together than alone. | Size: 229 KB 6th Oct 2015 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (52-Week) Improvements in Enthesitis and Dactylitis in Patients With Psoriatic Arthritis: Pooled Results From Three Phase III, Randomized, Controlled Trials. | Size: 230 KB 6th Oct 2015 Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational Registry, BioTRAC. | Size: 221 KB 6th Oct 2015 Folate Supplementation and Cancer Risk in Rheumatoid Arthritis Patients Exposed to Methotrexate. | Size: 221 KB 6th Oct 2015 Arthritis, gender, disability and incidence of Coronary Heart Disease: A longitudinal Canadian population-based cohort study. | Size: 219 KB 6th Oct 2015 Alterations of the Non-Canonical WNT/PKC Pathway in Human Osteoarthritis Osteoblasts. | Size: 227 KB 6th Oct 2015 Prevalence, Severity and Impact of Fecal Incontinence in Systemic Sclerosis: Preliminary Results of a Cross-Sectional Study. | Size: 220 KB 6th Oct 2015 Resveratrol Regulates the WNT/ ß-Catenin Pathway in Human Osteoaarthritis Osteoblasts. | Size: 221 KB 6th Oct 2015 Demographic and Disease Correlates of Clinically Significant Fatigue in Systemic Sclerosis: Preliminary Evidence Using Case-Definition Criteria. | Size: 220 KB 6th Oct 2015 Sociodemographic and Disease Correlates of Fatigue in Systemic Sclerosis. | Size: 220 KB 6th Oct 2015 Focus groups to inform the development of a scleroderma emotional distress coping tool. | Size: 220 KB 6th Oct 2015 Risk of Breast, Ovarian and Endometrial Cancers in Women with Rheumatoid Arthritis. | Size: 219 KB 6th Oct 2015 Breast, Ovarian and Endometrial Cancer in Women Diagnosed with SLE Before Age 40. | Size: 214 KB 6th Oct 2015 Une polyarthrite chronique révélant une lèpre.
| Size: 229 KB 26th Jan 2016 Further Reduction in Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With up to 7 Years in the FREEDOM Extension. | Size: 231 KB 26th Jan 2016 Could Estrogen Impact a New Pertinent Gene for Adolescent Idiopathic Scoliosis (AIS)? | Size: 235 KB 26th Jan 2016 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (52-Week) Improvement in Swollen and Tender Joint Counts in Patients With Psoriatic Arthritis: Results From Three Phase 3, Randomized, Controlled Trials. | Size: 226 KB 26th Jan 2016 The pan-Canadian Approach to Inflammatory Arthritis Models of Care. Michel Zummer | Size: 233 KB 26th Jan 2016 Depressive Symptoms at Baseline Predict Higher Simple Disease Activity Index (SDAI) Scores and Longer Time to Remission in Patients with Recent-Onset Arthritis. | Size: 227 KB 26th Jan 2016 Ultrasound Doppler activity correlates with systemic autoimmunity and swollen joints in a healthy population at risk for rheumatoid arthritis. | Size: 230 KB 26th Jan 2016 Redefining Dermatomyositis: Description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. | Size: 224 KB 26th Jan 2016 Sous hypoxie, les fibroblastes synoviaux sains et arthritiques révèlent des altérations du métabolisme des sphingolipides. | Size: 233 KB 26th Jan 2016 Laboratory Abnormalities in Patients With Psoriatic Arthritis Receiving Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials. | Size: 232 KB 26th Jan 2016 What investigations are needed to optimally monitor for malignancies in SLE? | Size: 224 KB 26th Jan 2016 Management of fragility fracture: an integrated interdisciplinary approach. | Size: 232 KB 26th Jan 2016 The role of marital satisfaction in emotional distress among women with scleroderma. | Size: 229 KB 26th Jan 2016 Anti-Ro antibodies and cancer in Systemic Lupus Erythematosus. | Size: 231 KB 26th Jan 2016 An international collaboration to conduct large-scale trials of non-pharmacological interventions in scleroderma: the Scleroderma Patient-centered Intervention Network (SPIN). | Size: 246 KB 26th Jan 2016 Recurrent hypocalcemia following denosumab in a patient with short bowel and renal impairment. | Size: 235 KB 26th Jan 2016 Can scores from English, French and Dutch versions of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) be pooled? An assessment of differential item functioning in patients with systemic sclerosis. | Size: 230 KB 26th Jan 2016 Lien entre l’antagoniste DKK2 et la réponse à la PTH par les ostéoblastes humains ostéoarthrosiques. | Size: 225 KB 26th Jan 2016 Estrogen receptor status and transcriptome profiling of genes regulated by 17-beta estradiol in human osteoblasts derived from idiopathic scoliosis patients. | Size: 227 KB 26th Jan 2016 PPAR Υ controls mTOR/autophagy signalling in the articular cartilage. Faezeh Vasheghani Farahan | Size: 227 KB 26th Jan 2016 LSD1-Mediated Demethylation of Histone H3 Lysine 9 Contributes to Interleukin 1-Induced Microsomal Prostaglandin E Synthase-1 Expression in Human Osteoarthritic Chondrocytes.
| Size: 226 KB 27th Jan 2016 Les effets paradoxaux des agents anti-TNF | Size: 225 KB 27th Jan 2016 Joint Action on Arthritis: A Framework to Improve Arthritis Prevention and Care in Canada. | Size: 239 KB 27th Jan 2016 Denosumab Compared with Risedronate in Postmenopausal Women Suboptimally Adherent with Alendronate Therapy: Efficacy and Safety Results from a Randomized Open-Label Study. | Size: 224 KB 27th Jan 2016 One-Year Results from the Canadian CAMEO Study: A Trial of Etanercept and Methotrexate versus Etanercept Alone in Rheumatoid Arthritis. | Size: 230 KB 27th Jan 2016 The role of toll-like receptor-4 (TLR-4) activation in a murine model of systemic lupus erythematosus (SLE). | Size: 233 KB 27th Jan 2016 Hypoxia in human osteoarthritic subchondral bone: a risk factor for leptin production by osteoblasts. | Size: 232 KB 27th Jan 2016 Metabolic Factors, Biomechanical Stress and Estrogen Impact on Osteoblasts. | Size: 238 KB 27th Jan 2016 Induced Abortions in Women with Systemic Sclerosis. | Size: 229 KB 27th Jan 2016 A roadmap to personalized medicine in Rheumatoid Arthritis using anti-Sa antibody titers to monitor the immunopathologically driven, clinical disease activity. | Size: 240 KB 27th Jan 2016 An Autoimmune Myositis-Overlap Syndrome Associated with Autoantibodies to Nuclear Pore Complexes. Description and Long-Term Follow-Up of the Anti-Nup Syndrome. | Size: 226 KB 27th Jan 2016 Rheumatoid Arthritis Prevalence in Quebec. | Size: 236 KB 27th Jan 2016 Measurement of Pulmonary Arteries by Cardiac Magnetic Resonance Imaging: A Simple and Useful Tool for the Detection of Pulmonary Hypertension in Systemic Sclerosis Patients without Overt Cardiac Microvascular Perfusion Defects or Fibrosis. | Size: 233 KB 27th Jan 2016 Effects of Vitamin D Repletion and Maintenance Therapy on RA Characteristics and Quality of Life. | Size: 234 KB 27th Jan 2016 Gender and Time to Diagnosis in Systemic Sclerosis: An Updated Analysis of 1,129 Patients from the Canadian Scleroderma Research Group Registry | Size: 228 KB 27th Jan 2016 Expression of PPARa, b, g, and H- and L-PGDS during Osteoarthritis in the Spontaneous Hartley Guinea Pig and the Experimental Dog Models | Size: 241 KB 27th Jan 2016 Low Prevalence of Myocardial Fibrosis by Cardiac Magnetic Resonance Imaging in 39 French Canadian Systemic Sclerosis Patients: Comparison of the CHUM Cohort with other World Cohorts. | Size: 237 KB 27th Jan 2016 Prevalence of Current, 12-Month, and Lifetime Major Depressive Disorder among Patients with Systemic Sclerosis. | Size: 233 KB 27th Jan 2016 Targeting fear of disease progression in rheumatic diseases: a case study in systemic sclerosis. | Size: 226 KB 27th Jan 2016 H3K9 demethylation by LSD1 contributes to IL-1-induced mPGES-1 expression in OA chondrocytes. | Size: 233 KB 27th Jan 2016 Increased Body Mass Index Among RA Patients. | Size: 230 KB 27th Jan 2016 Inducible cartilage-specific PPARgamma-deficient mice exhibit accelerated experimentally-induced osteoarthritis associated with defective autophagy and mTOR signaling. | Size: 229 KB 27th Jan 2016 Low Sirtuin 1 levels in human Osteoarthritis Subchondral Osteoblasts lead to abnormal Sclerostin expression which decreases Wnt/β-catenin activity. | Size: 227 KB 27th Jan 2016 Clinically Apparent Arterial Thrombosis in Persons with Systemic Vasculitis.